Australian health insurers and pharmaceutical companies reckon with new psychedelic mental health treatments

While very few patients are expected to access new psychedelic therapies when regulatory changes take effect next month, medicinal cannabis companies, drug developers and health insurers are keeping watch on the emerging industry.

Related Keywords

Canada ,Melbourne ,Victoria ,Australia ,Afghanistan ,Monash ,South Australia ,Perth ,Western Australia ,Abbotsford ,British Columbia ,Iraq ,Australian ,Australians ,Canadian ,Rodney Cocks ,Robert Mcgrath ,Peter Widdows ,Shaun Duffy ,Optimi Health Corp ,Vitura Health ,Incannex Healthcare ,Pharmala Biotech Holdings ,British Embassy ,Health Insurance Fund Of Australia ,Zealand College Of Psychiatrists ,Therapeutic Goods Administration ,Monash University ,Pharmala Biotech ,Green Pharma ,Reset Mind ,Reset Mind Sciences ,Health Insurance Fund ,Incannex Healthcare Limited ,Mind Medicine Australia ,Mind Medicine Australia Managed ,Royal Australian ,New Zealand College ,Tga Decision ,Psychedelic Therapy ,Dma ,Silocybin ,Ptsd ,Post Traumatic Stress Disorder ,Little Green Pharma ,Health Insurance ,